OP Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.6M Buy
310,902
+116,145
+60% +$25.8M 0.68% 24
2025
Q4
$44.5M Sell
194,757
-14,269
-7% -$3.25M 0.53% 28
2025
Q3
$48.4M Buy
209,026
+3,727
+2% +$759K 0.62% 27
2025
Q2
$38.1M Buy
205,299
+6,719
+3% +$1.25M 0.55% 28
2025
Q1
$41.6M Buy
+198,580
New +$38.6M 0.68% 25

Other funds holding ABBV

OP Asset Management's ABBV Position: Q1 2026 in Review

OP Asset Management increased its AbbVie (ABBV) stake by 60% in Q1 2026, buying an estimated $25.8M and bringing the position to 310,902 shares worth $67.6M. The position accounts for 0.68% of the portfolio, ranked #24.

OP Asset Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • OP Asset Management held 310,902 shares of AbbVie worth $67.6M as of Q1 2026.
  • OP Asset Management bought 116,145 AbbVie shares in Q1 2026, an estimated $25.8M.
  • AbbVie made up 0.68% of OP Asset Management's portfolio in Q1 2026, its #24 holding.
  • OP Asset Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.